Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Plasma cell 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1Anxiety Disorders 1

Interventions

Blood Specimen Collection 35Methods 25Early Intervention, Educational 24Standard of Care 21Colposcopy 21Surveys and Questionnaires 19Educational Status 18Sentinel Lymph Node Biopsy 17Cisplatin 17Counseling 16Brachytherapy 16Exercise 15Interviews as Topic 13Carboplatin 13Therapeutics 12Surgical Procedures, Operative 11Paclitaxel 11Magnetic Resonance Spectroscopy 11Indocyanine Green 11Biopsy 11Radiotherapy 10Practice Guidelines as Topic 10Palliative Care 10Human Papillomavirus DNA Tests 10Behavior Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Psychiatric Rehabilitation 9Lymph Node Excision 9Genetic Testing 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Propranolol × Gynecologic × Clear all
NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
35 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡